Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome

<div>Different metabolic pathways were strongest affected by QD or YD in CRC serum samples. (a) Venn diagram showing overlap among metabolites differentially expressed in serum samples of CRC patients with QD, YD, or ND. (b, c, and d) Schematic representation of galactose metabolism (b), tRNA synthesis (c), and alpha-linolenic acid metabolism (d) pathway. In red, the metabolites that differentially expressed in serum samples of CRC patients with QD, YD, or ND.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome 

Figure 3 | Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome 